On June 25, Wang Haitao, General Manager of Jingpai Zhizhengtang Pharmaceutical Co., Ltd., led a delegation to the company for a business exchange and to explore potential collaboration opportunities.

During the discussion, both parties focused on common industry pain points and future trends, exchanged views on market positioning, marketing strategies, and brand competitiveness enhancement, and shared practical experiences in optimizing sales systems, reducing costs through supply chain collaboration, and standardizing production processes.

Wang Haitao highly commended Chun Guang Jiu Hui's achievements in standardizing and modernizing traditional Chinese medicine, particularly its breakthroughs in ultra-fine powder technology, industrialized R&D of formula granules, and nationwide market network development. He also shared insights into Jing Pai Chi Zheng Tang's evolution in the formula granule sector and its future strategic roadmap.

Shen Fanshun, the company's Party branch secretary and chairman, emphasized that peer exchanges drive industry progress. The company is eager to share its expertise in technological innovation and quality management. He commended Jingpai Chizhengtang for its achievements in brand operations and market expansion, and expressed hope for deeper collaboration through more interactions in the future.

This exchange highlighted the shared vision of both companies in inheriting and innovating traditional Chinese medicine, deepened mutual understanding and trust, and laid a solid foundation for their future comprehensive and in-depth cooperation.